Fragile sites are intriguing cytogenetic phenomena that have been extensively investigated in human and laboratory animal chromosomes over the past 40 years, but domestic animal species have been studied sporadically. Interest in the field has been recently renewed as increasing numbers of fragile site regions are cloned and characterized at the molecular level. Despite much effort, mechanisms by which specific DNA sequence confers fragility to a chromosome region remain unclear. Recent advancements in sequencing and mapping of domestic animal genomes provide tools for molecular characterization of fragile sites in animal chromosomes. Future comparative efforts may contribute insight into both the mechanisms that underlie chromosome fragility, and forces that drive rearrangements observed throughout evolution, and somatic changes that can result in disease or impair fertility.

Keywords:
Biosensor, Chromosome breakage, Comparative genomics, Equine fertility, Livestock
1.
Aguilera A, Gomez-Gonzalez B: Genome instability: A mechanistic view of its causes and consequences. Nat Rev Genet 9:204–217 (2008).
2.
Ahmed S: New classes of fragile sites in buffalo chromosomes. Cytologia 70:415–419 (2005).
3.
Ali A, Abdullah M, Babar ME, Javed K, Nadeem A: Expression and identification of folate-sensitive fragile sites in British Suffolk sheep (Ovis aries). J Genet 87:219–227 (2008).
4.
Arlt MF, Miller DE, Beer DG, Glover TW: Molecular characterization of FRAXB and comparative common fragile site instability in cancer cells. Genes Chromosomes Cancer 33:82–92 (2002).
5.
Auerbach C, Robson JM: The chemical production of mutations. Nature 157:302 (1946).
6.
Basrur PK, Gilman JPW: Observations of calves with hereditary exfoliate dermatosis (baldy calf syndrome). Somatic Cell Genetics Conference, Abstract 6 (1966).
7.
Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA, et al: WWOX, a novel ww domain-containing protein mapping to human chromosome 16q23.3–24.1, a region frequently affected in breast cancer. Cancer Res 60:2140–2145 (2000).
8.
Benet J, Fuster C, Genesca A, Navarro J, Miro R, et al: Expression of fragile sites in human sperm and lymphocyte chromosomes. Hum Genet 81:239–242 (1989).
9.
Bueno MJ, Perez de Castro I, Gomez de Cedron M, Santos J, Calin GA, et al: Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13:496–506 (2008).
10.
Burrow AA, Williams LE, Pierce LC, Wang YH: Over half of breakpoints in gene pairs involved in cancer-specific recurrent translocations are mapped to human chromosomal fragile sites. BMC Genomics 10:59 (2009).
11.
Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101:2999–3004 (2004).
12.
Callahan G, Denison SR, Phillips LA, Shridhar V, Smith DI: Characterization of the common fragile site FRA9E and its potential role in ovarian cancer. Oncogene 22:590–601 (2003).
13.
Cannizzaro LA, Durst M, Mendez MJ, Hecht BK, Hecht F: Regional chromosome localization of human papillomavirus integration sites near fragile sites, oncogenes, and cancer chromosome breakpoints. Cancer Genet Cytogenet 33:93–98 (1988).
14.
Carbone L, Harris RA, Vessere GM, Mootnick AR, Humphray S, et al: Evolutionary breakpoints in the gibbon suggest association between cytosine methylation and karyotype evolution. PLoS Genet 5:e1000538 (2009).
15.
Casper AM, Nghiem P, Arlt MF, Glover TW: ATR regulates fragile site stability. Cell 111:779–789 (2002).
16.
Ciullo M, Debily MA, Rozier L, Autiero M, Billault A, et al: Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: The model of PIP gene duplication from a break at FRA7I. Hum Mol Genet 11:2887–2894 (2002).
17.
Cribiu EP, Durand V, Saget O, Chaffaux S: Cytogenetic investigations in Booroola Merinos d’Arles sheep (preliminary results): major genes for reproduction in sheep. 2nd International Workshop, pp 305–311 (INRA, Toulouse 1991).
18.
Curatolo A, Limongi ZM, Pelliccia F, Rocchi A: Molecular characterization of the human common fragile site FRA1H. Genes Chromosomes Cancer 46:487–493 (2007).
19.
Debacker K, Kooy RF: Fragile sites and human disease. Hum Mol Genet 16 Spec No. 2:R150–158 (2007).
20.
Debacker K, Winnepenninckx B, Longman C, Colgan J, Tolmie J, et al: The molecular basis of the folate-sensitive fragile site FRA11A at 11q13. Cytogenet Genome Res 119:9–14 (2007a).
21.
Debacker K, Winnepenninckx B, Ben-Porat N, FitzPatrick D, Van Luijk R, et al: FRA18C: A new aphidicolin-inducible fragile site on chromosome 18q22, possibly associated with in vivo chromosome breakage. J Med Genet 44:347–352 (2007b).
22.
De Braekeleer M, Smith B, Lin CC: Fragile sites and structural rearrangements in cancer. Hum Genet 69:112–116 (1985).
23.
Dekaban A: Persisting clone of cells with an abnormal chromosome in a woman previously irradiated. J Nucl Med 6:740–746 (1965).
24.
Denison SR, Wang F, Becker NA, Schule B, Kock N, et al: Alterations in the common fragile site gene PARKIN in ovarian and other cancers. Oncogene 22:8370–8378 (2003).
25.
DiBerardino D, Iannuzzi I, DiMeo GP: Localisation of BrdU-induced break sites in bovine chromosomes. Cytologia 36:285–292 (1983).
26.
Djalali M, Barbi G, Steinbach P: Folic acid sensitive fragile sites are not limited to the human karyotype. Demonstration of nonrandom gaps and breaks in the Persian vole Ellobius lutescens th. inducible by methotrexate, fluorodeoxyuridine, and aphidicolin. Hum Genet 70:183–185 (1985).
27.
Djalali M, Adolph S, Steinbach P, Winking H, Hameister H: A comparative mapping study of fragile sites in the human and murine genomes. Hum Genet 77:157–162 (1987).
28.
Durkin SG, Glover TW: Chromosome fragile sites. Annu Rev Genet 41:169–192 (2007).
29.
Durkin SG, Ragland RL, Arlt MF, Mulle JG, Warren ST, et al: Replication stress induces tumor-like microdeletions in FHIT/FRA3B. Proc Natl Acad Sci USA 105:246–251 (2008).
30.
Dutrillaux B, Viegas-Pequignot E, Couturier J: Tres grande analogie de marquage chromosomique entre le lapin (Oryctolagus cuniculus) et les primates dont l’homme. Ann Genet (Paris) 23:22–25 (1980).
31.
Elder FF, Robinson TJ: Rodent common fragile sites: Are they conserved? Evidence from mouse and rat. Chromosoma 97:459–464 (1989).
32.
Engelman JA, Zhang XL, Lisanti MP: Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers. FEBS Lett 436:403–410 (1998).
33.
Fechter A, Buettel I, Kuehnel E, Schwab M, Savelyeva L: Cloning of genetically tagged chromosome break sequences reveals new fragile sites at 6p21 and 13q22. Int J Cancer 120:2359–2367 (2007a).
34.
Fechter A, Buettel I, Kuehnel E, Savelyeva L, Schwab M: Common fragile site FRA11G and rare fragile site FRA11B at 11q23.3 encompass distinct genomic regions. Genes Chromosomes Cancer 46:98–106 (2007b).
35.
Felbor U, Feichtinger W, Schmid M: The rare human fragile site 16B. Cytogenet Genome Res 100:85–88 (2003).
36.
Ferber MJ, Eilers P, Schuuring E, Fenton JA, Fleuren GJ, et al: Positioning of cervical carcinoma and Burkitt lymphoma translocation breakpoints with respect to the human papillomavirus integration cluster in FRA8C at 8q24.13. Cancer Genet Cytogenet 154:1–9 (2004).
37.
Freudenreich CH: Chromosome fragility: Molecular mechanisms and cellular consequences. Front Biosci 12:4911–4924 (2007).
38.
Gamboa S, Ramalho-Santos J: Snare proteins and caveolin-1 in stallion spermatozoa: Possible implications for fertility. Theriogenology 64:275–291 (2005).
39.
Garcia-Sagredo JM, San Roman C, Gallego Gomez ME, Lledo G: Fragile chromosome 16(q22) cause a balanced translocation at the same point. Hum Genet 65:211–213 (1983).
40.
Gecz J, Gedeon AK, Sutherland GR, Mulley JC: Identification of the gene FMR2, associated with FRAXE mental retardation. Nat Genet 13:105–108 (1996).
41.
Glover T: Biochemistry of fragile site expression; in Sutherland GR, Hecht F (eds): Fragile Sites on Human Chromosomes (Oxford University Press, New York 1985).
42.
Glover TW, Hoge AW, Miller DE, Ascara-Wilke JE, Adam AN, et al: The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region. Cancer Res 58:3409–3414 (1998).
43.
Gordon L, Yang S, Tran-Gyamfi M, Baggott D, Christensen M, et al: Comparative analysis of chicken chromosome 28 provides new clues to the evolutionary fragility of gene-rich vertebrate regions. Genome Res 17:1603–1613 (2007).
44.
Gripenberg U, Huuhtanen S, Wessman M, Nieminen M: A fragile site in the X chromosome of the reindeer (Rangifer tarandus L.). Genet Sel Evol 23:135s–139s (1991).
45.
Gustavsson I: Chromosomes of the pig; in McFeely RA (ed): Domestic Animal Cytogenetics, pp 131–167 (Academic Press, San Diego 1990).
46.
Hamann H, Jude R, Sieme H, Mertens U, Topfer-Petersen E, et al: A polymorphism within the equine CRISP3 gene is associated with stallion fertility in Hanoverian warmblood horses. Anim Genet 38:259–264 (2007).
47.
Hayman D, Sharp P: Hoechst 33258 induced uncondensed sites in marsupial chromosomes. Chromosoma 83:249–262 (1981).
48.
Haynes SE, Reisner AH: Cytogenetic and DNA analyses of equine abortion. Cytogenet Cell Genet 34:204–214 (1982).
49.
Hecht F, Glover TW: Cancer chromosome breakpoints and common fragile sites induced by aphidicolin. Cancer Genet Cytogenet 13:185–188 (1984).
50.
Hecht F, Kaiser-McCaw B: The importance of being a fragile site. Am J Hum Genet 31:223–225 (1979).
51.
Hecht F, Tajara EH, Lockwood D, Sandberg AA, Hecht BK: New common fragile sites. Cancer Genet Cytogenet 33:1–9 (1988).
52.
Hecht F, Ramesh KH, Lockwood DH: A guide to fragile sites on human chromosomes. Cancer Genet Cytogenet 44:37–45 (1990).
53.
Helmrich A, Stout-Weider K, Hermann K, Schrock E, Heiden T: Common fragile sites are conserved features of human and mouse chromosomes and relate to large active genes. Genome Res 16:1222–1230 (2006).
54.
Helmrich A, Stout-Weider K, Matthaei A, Hermann K, Heiden T, et al: Identification of the human/mouse syntenic common fragile site FRA7K/Fra12c1 – relation of FRA7K and other human common fragile sites on chromosome 7 to evolutionary breakpoints. Int J Cancer 120:48–54 (2007).
55.
Hewett DR, Handt O, Hobson L, Mangelsdorf M, Eyre HJ, et al: FRA10B structure reveals common elements in repeat expansion and chromosomal fragile site genesis. Mol Cell 1:773–781 (1998).
56.
Hormozian F, Schmitt JG, Sagulenko E, Schwab M, Savelyeva L: FRA1E common fragile site breaks map within a 370 kilobase pair region and disrupt the dihydropyrimidine dehydrogenase gene (DPYD). Cancer Lett 246:82–91 (2007).
57.
Hsu TC, Somers CE: Effect of 5-bromodeoxyuridine on mammalian chromosomes. Proc Natl Acad Sci USA 47:396–403 (1961).
58.
Huang J, Ma L, Yang F, Fei SZ, Li L: 45S rDNA regions are chromosome fragile sites expressed as gaps in vitro on metaphase chromosomes of root-tip meristematic cells in Lolium spp. PLoS ONE 3:e2167 (2008).
59.
Huppi K, Volfovsky N, Runfola T, Jones TL, Mackiewicz M, et al: The identification of microRNAs in a genomically unstable region of human chromosome 8q24. Mol Cancer Res 6:212–221 (2008).
60.
Iannuzzi L, Di Meo GP, Perucatti A, Schibler L, Incarnato D, et al: The river buffalo (Bubalus bubalis, 2n = 50) cytogenetic map: Assignment of 64 loci by fluorescence in situ hybridization and R-banding. Cytogenet Genome Res 102:65–75 (2003).
61.
Iannuzzi L, Perucatti A, Di Meo GP, Polimeno F, Ciotola F, et al: Chromosome fragility in two sheep flocks exposed to dioxins during pasturage. Mutagenesis 19:355–359 (2004).
62.
ISCN: An international system for human cytogenetic nomenclature (1985) ISCN 1985. Report of the standing committee on human cytogenetic nomenclature. Birth Defects Orig Artic Ser 21:1–117 (1985).
63.
Jones C, Penny L, Mattina T, Yu S, Baker E, et al: Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. Nature 376:145–149 (1995).
64.
Jones C, Mullenbach R, Grossfeld P, Auer R, Favier R, et al: Co-localisation of CCG repeats and chromosome deletion breakpoints in Jacobsen syndrome: Evidence for a common mechanism of chromosome breakage. Hum Mol Genet 9:1201–1208 (2000).
65.
Kihlman BA: Actions of Chemicals on Dividing Cells (Prentice-Hall, Inc., New Jersey 1966).
66.
Kihlman BA, Nichols WW, Levan A: The effect of deoxyadenosine and cytosine arabinoside on the chromosomes of human leukocytes in vitro. Hereditas 50:139–143 (1963).
67.
Kraus I, Driesch C, Vinokurova S, Hovig E, Schneider A, et al: The majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences of known or predicted genes. Cancer Res 68:2514–2522 (2008).
68.
Kremer EJ, Pritchard M, Lynch M, Yu S, Holman K, et al: Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252:1711–1714 (1991).
69.
Krumdieck CL, Howard-Peebles PN: On the nature of folic-acid-sensitive fragile sites in human chromosomes: An hypothesis. Am J Med Genet 16:23–28 (1983).
70.
Lahbib-Mansais Y, Tosser-Klopp G, Leroux S, Cabau C, Karsenty E, et al: Contribution to high-resolution mapping in pigs with 101 type I markers and progress in comparative map between humans and pigs. Mamm Genome 14:275–288 (2003).
71.
Lear TL, Lundquist J, Zent WW, Fishback WD Jr, Clark A: Three autosomal chromosome translocations associated with repeated early embryonic loss (REEL) in the domestic horse (Equus caballus). Cytogenet Genome Res 120:117–122 (2008).
72.
Le Beau MM: Chromosomal fragile sites and cancer-specific rearrangements. Blood 67:849–858 (1986).
73.
Le Beau MM, Rowley JD: Heritable fragile sites in cancer. Nature 308:607–608 (1984).
74.
Le Beau MM, Drabkin H, Glover TW, Gemmill R, Rassool FV, et al: An FHIT tumor suppressor gene? Genes Chromosomes Cancer 21:281–289 (1998).
75.
Ledbetter DH, Ledbetter SA, Nussbaum RL: Implications of Fragile X expression in normal males for the nature of the mutation. Nature 324:161–163 (1986).
76.
Lejeune J, Dutrillaux B, Lafourcade J, Berger R, Abonyi D, et al: Selective endoreduplication of the long arm of the 2 chromosome in a woman and her daughter. C R Acad Sci Hebd Seances Acad Sci D 266:24–26 (1968).
77.
Lemieux N, Dutrillaux B: New gene assignment to rabbit chromosomes: Implications for chromosome evolution. Cytogenet Cell Genet 61:132–134 (1992).
78.
Limongi MZ, Pelliccia F, Rocchi A: Characterization of the human common fragile site FRA2G. Genomics 81:93–97 (2003).
79.
Lin MS, Takabayashi T, Wilson MG, Marchese CA: An in vitro and in vivo study of a BrdU-sensitive fragile site in the Chinese hamster. Cytogenet Cell Genet 38:211–215 (1984).
80.
Long SE: Reciprocal translocation in the pig (Sus scrofa): A review. Vet Record 128:275–278 (1991).
81.
Long SE: Tandem 1;30 translocation: A new structural abnormality in the horse (Equus caballus). Cytogenet Cell Genet 72:162–163 (1996).
82.
Lubs HA: A marker X chromosome. Am J Hum Genet 21:231–244 (1969).
83.
Lukusa T, Fryns JP: Human chromosome fragility. Biochim Biophys Acta 1779:3–16 (2008).
84.
Magenis RE, Hecht F, Lovrien EW: Heritable fragile site on chromosome 16: Probable localization of haptoglobin locus in man. Science 170:85–87 (1970).
85.
Maglott D, Ostell J, Pruitt KD, Tatusova T: Entrez gene: Gene-centered information at NCBI. Nucleic Acids Res 33:D54–D58 (2005).
86.
Mahrous K, Ahmed S: Fragile sites in Egyptian water buffalo. Cytologia 65:313–317 (2000).
87.
Matejka M, Cribiu EP, Ricordeau G, Eychenne F, Durand V, et al: Evidence for rare heritable fragile site in Romanov sheep chromosome 8. Reproduction in Domestic Animals 25:220–226 (1990).
88.
Mather K, Stone LHA: The effect of X-radiation upon somatic chromosomes. J Genet 28:1–24 (1933).
89.
McAllister BF, Greenbaum IF: How common are common fragile sites: Variation of aphidicolin-induced chromosomal fragile sites in a population of the deer mouse (Peromyscus maniculatus). Hum Genet 100:182–188 (1997).
90.
McAvoy S, Zhu Y, Perez DS, James CD, Smith DI: Disabled-1 is a large common fragile site gene, inactivated in multiple cancers. Genes Chromosomes Cancer 47:165–174 (2008).
91.
McClintock B: The behavior in successive nuclear divisions of a chromosome broken at meiosis. Proc Natl Acad Sci USA 25:405–416 (1939).
92.
McClintock B: The stability of broken ends of chromosomes in Zea mays. Genetics 26:234–282 (1941).
93.
Miller CT, Lin L, Casper AM, Lim J, Thomas DG, et al: Genomic amplification of met with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma. Oncogene 25:409–418 (2006).
94.
Miro R, Clemente IC, Fuster C, Egozcue J: Fragile sites, chromosome evolution, and human neoplasia. Hum Genet 75:345–349 (1987).
95.
Mishmar D, Rahat A, Scherer SW, Nyakatura G, Hinzmann B, et al: Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc Natl Acad Sci USA 95:8141–8146 (1998).
96.
Morelli C, Karayianni E, Magnanini C, Mungall AJ, Thorland E, et al: Cloning and characterization of the common fragile site fra6f harboring a replicative senescence gene and frequently deleted in human tumors. Oncogene 21:7266–7276 (2002).
97.
Muller HJ: Artificial transmutation of the gene. Science 66:84–87 (1927).
98.
Murphy WJ, Larkin DM, Everts-van der Wind A, Bourque G, Tesler G, et al: Dynamics of mammalian chromosome evolution inferred from multispecies comparative maps. Science 309:613–617 (2005).
99.
Nancarrow JK, Kremer E, Holman K, Eyre H, Doggett NA, et al: Implications of FRA16A structure for the mechanism of chromosomal fragile site genesis. Science 264:1938–1941 (1994).
100.
Nicodemo D, Coppola G, Pauciullo A, Cosenza G, Ramunno L, et al: Mapping fragile-sites in the standard karyotype of river buffalo (Bubalus bubalis, 2n = 50). Italian J Anim Sci 6:291–294 (2007).
101.
Nicodemo D, Coppola G, Pauciullo A, Cosenza G, Ramunno L, et al: Chromosomal expression and localization of aphidicolin-induced fragile sites in the standard karyotype of river buffalo (Bubalus bubalis). Cytogenet Genome Res 120:178–182 (2008).
102.
Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, et al: The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587–597 (1996).
103.
Oliveira DAA, Pinheiro LEL, Miranda J: Chromosome abnormalities in pig breeding herds. Revista Brasileira de Reproducao Animal 13:239–245 (1989).
104.
Paige AJ, Taylor KJ, Stewart A, Sgouros JG, Gabra H, et al: A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D. Cancer Res 60:1690–1697 (2000).
105.
Paradee W, Wilke CM, Wang L, Shridhar R, Mullins CM, et al: A 350-kb cosmid contig in 3p14.2 that crosses the t(3;8) hereditary renal cell carcinoma translocation breakpoint and 17 aphidicolin-induced FRA3B breakpoints. Genomics 35:87–93 (1996).
106.
Pascual I, Arruga MV: Detection and placing of chromosomal aberrations in sheep (Ovis aries). Archivos de Zootecnia 45:251–257 (1996).
107.
Pelliccia F, Bosco N, Curatolo A, Rocchi A: Replication timing of two human common fragile sites: FRA1H and FRA2G. Cytogenet Genome Res 121:196–200 (2008).
108.
Pichiorri F, Ishii H, Okumura H, Trapasso F, Wang Y, et al: Molecular parameters of genome instability: Roles of fragile genes at common fragile sites. J Cell Biochem 104:1525–1533 (2008).
109.
Pires RM, Reichert RH, Kasahara S: Cytogenetics of three breeds of river buffalo (Bubalus bubalis L.), with evidence of a fragile site on the X chromosome. Theriogenology 49:529–538 (1998).
110.
Pirzio LM, Pichierri P, Bignami M, Franchitto A: Werner syndrome helicase activity is essential in maintaining fragile site stability. J Cell Biol 180:305–314 (2008).
111.
Popescu NC, DiPaolo JA: Preferential sites for viral integration on mammalian genome. Cancer Genet Cytogenet 42:157–171 (1989).
112.
Poulsen BS, Rønne M: High resolution R-banding and localization of fragile sites in Oryctolagus cuniculus. Genet Sel Evol 23:183s–186s (1991).
113.
Poulsen BS, Shibasaki Y, Rønne M: The high resolution R-banded karyotype of Oryctolagus cuniculus L. Hereditas 109:57–60 (1988).
114.
Raghavan SC, Chastain P, Lee JS, Hegde BG, Houston S, et al: Evidence for a triplex DNA conformation at the bcl-2 major breakpoint region of the t(14;18) translocation. J Biol Chem 280:22749–22760 (2005).
115.
Ragland RL, Glynn MW, Arlt MF, Glover TW: Stably transfected common fragile site sequences exhibit instability at ectopic sites. Genes Chromosomes Cancer 47:860–872 (2008).
116.
Rassool FV, Le Beau MM, Shen ML, Neilly ME, Espinosa R 3rd, et al: Direct cloning of DNA sequences from the common fragile site region at chromosome band 3p14.2. Genomics 35:109–117 (1996).
117.
Revell SH: Chromosome breakage by X-rays and radiomimetic substances in Vicia. Heredity 6:107–124 (1953).
118.
Riggs PK, Chrisman CL: Preliminary analyses of Aphidicolin-induced fragile sites in pig chromosomes: 6th North American Colloquium on Cytogenetics of Domestic Animals, p 4 (Purdue University, West Lafayette, Ind. 1989).
119.
Riggs PK, Kuczek T, Chrisman CL, Bidwell CA: Analysis of aphidicolin-induced chromosome fragility in the domestic pig (Sus scrofa). Cytogenet Cell Genet 62:110–116 (1993).
120.
Robinson TJ, Elder FF: Multiple common fragile sites are expressed in the genome of the laboratory rat. Chromosoma 96:45–49 (1987).
121.
Rodriguez V, Llambi S, Postiglioni A, Guevara K, Rincon G, et al: Localisation of aphidicolin-induced break points in Holstein-Friesian cattle (Bos taurus) using RBG-banding. Genet Sel Evol 34:649–656 (2002).
122.
Rønne M: Putative fragile sites in the horse karyotype. Hereditas 117:127–136 (1992).
123.
Rønne M: Localization of fragile sites in the karyotype of Sus scrofa domestica: Present status. Hereditas 122:153–162 (1995a).
124.
Rønne M: Localization of fragile sites in the karyotype of Felis catus. Hereditas 122:279–283 (1995b).
125.
Rønne M, Riggs P, Gyldenholm A, Storm O: Fragile Sites and Fertility in Horses: 10th European Colloquium on Cytogenetics of Domestic Animals, pp 197–200 (Utrecht, The Netherlands, 1992).
126.
Rozier L, El-Achkar E, Apiou F, Debatisse M: Characterization of a conserved aphidicolin-sensitive common fragile site at human 4q22 and mouse 6C1: Possible association with an inherited disease and cancer. Oncogene 23:6872–6880 (2004).
127.
Ruiz-Herrera A, Robinson TJ: Chromosomal instability in Afrotheria: Fragile sites, evolutionary breakpoints and phylogenetic inference from genome sequence assemblies. BMC Evol Biol 7:199 (2007).
128.
Ruiz-Herrera A, Castresana J, Robinson TJ: Is mammalian chromosomal evolution driven by regions of genome fragility? Genome Biol 7:R115 (2006).
129.
Sanghamitra K, Patel RK, Sambasiva Rao KRS, Singh KM: Preliminary study on detection of fragile site on chromosomes of sub-fertile Murrah buffalo bulls. Harayana Veterinarian 43:68–71 (2004).
130.
Sanz MM, Jenkins EC, Brown WT, Davisson MT, Kevin MJ, et al: Mouse chromosome fragility. Am J Med Genet 23:491–509 (1986).
131.
Sarafidou T, Kahl C, Martinez-Garay I, Mangelsdorf M, Gesk S, et al: Folate-sensitive fragile site FRA10A is due to an expansion of a CGG repeat in a novel gene, FRA10AC1, encoding a nuclear protein. Genomics 84:69–81 (2004).
132.
Savelyeva L, Sagulenko E, Schmitt JG, Schwab M: The neurobeachin gene spans the common fragile site FRA13A. Hum Genet 118:551–558 (2006).
133.
Schlegelberger B, Gripp K, Grote W: Common fragile sites in couples with recurrent spontaneous abortions. Am J Med Genet 32:45–51 (1989).
134.
Schmid M, Ott G, Haaf T, Scheres JM: Evolutionary conservation of fragile sites induced by 5-azacytidine and 5-azadeoxycytidine in man, gorilla, and chimpanzee. Hum Genet 71:342–350 (1985).
135.
Schneider NR, Chaganti RS, German J: Analysis of a BrdU-sensitive site in the cactus mouse (Peromyscus eremicus): Chromosomal breakage and sister-chromatid exchange. Chromosoma 77:379–389 (1980).
136.
Schwartz M, Zlotorynski E, Kerem B: The molecular basis of common and rare fragile sites. Cancer Lett 232:13–26 (2006).
137.
Seuánez HN: The Phylogeny of Human Chromosomes, p 189 (Springer-Verlag, Berlin 1979).
138.
Shabtai F, Bichacho S, Halbrecht I: The fragile site on chromosome 16 (q21q22). Data on four new families. Hum Genet 55:19–22 (1980).
139.
Shann YJ, Cheng C, Chiao CH, Chen DT, Li PH, et al: Genome-wide mapping and characterization of hypomethylated sites in human tissues and breast cancer cell lines. Genome Res 18:791–801 (2008).
140.
Sharma AK, Sharma A: Spontaneous and chemically induced chromosome breaks. Int Rev Cytol 10:101–136 (1960).
141.
Shaw MA, Chiurazzi P, Romain DR, Neri G, Gecz J: A novel gene, FAM11A, associated with the FRAXF CpG island is transcriptionally silent in FRAXF full mutation. Eur J Hum Genet 10:767–772 (2002).
142.
Sherman SL, Jacobs PA, Morton NE, Froster-Iskenius U, Howard-Peebles PN, et al: Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet 69:289–299 (1985).
143.
Simi S, Vatteroni L, Piras A, Mariani T, Rainaldi G: Folate-sensitive fragile sites in Chinese hamster cell lines. Cancer Genet Cytogenet 46:209–216 (1990).
144.
Smeets DF, van de Klundert FA: Common fragile sites in man and three closely related primate species. Cytogenet Cell Genet 53:8–14 (1990).
145.
Smith DI, Zhu Y, McAvoy S, Kuhn R: Common fragile sites, extremely large genes, neural development and cancer. Cancer Lett 232:48–57 (2006).
146.
Smith DI, McAvoy S, Zhu Y, Perez DS: Large common fragile site genes and cancer. Semin Cancer Biol 17:31–41 (2007).
147.
Stadler LJ: Genetic effects of X-rays in maize. Proc Natl Acad Sci USA 14:69–75 (1928).
148.
Stadler LJ: Experimental modification of heredity in crop plants. I. Induced chromosomal irregularities. Sci Agric 11 (1931).
149.
Stone DM, Jacky PB, Hancock DD, Prieur DJ: Chromosomal fragile site expression in dogs: I. Breed specific differences. Am J Med Genet 40:214–222 (1991a).
150.
Stone DM, Jacky PB, Prieur DJ: Chromosomal fragile site expression in dogs: II. Expression in boxer dogs with mast cell tumors. Am J Med Genet 40:223–229 (1991b).
151.
Stone DM, Stephens KE, Doles J: Folate-sensitive and aphidicolin-inducible fragile sites are expressed in the genome of the domestic cat. Cancer Genet Cytogenet 65:130–134 (1993).
152.
Sutherland GR: Fragile sites on human chromosomes: Demonstration of their dependence on the type of tissue culture medium. Science 197:265–266 (1977).
153.
Sutherland GR: Heritable fragile sites on human chromosomes. I. Factors affecting expression in lymphocyte culture. Am J Hum Genet 31:125–135 (1979).
154.
Sutherland GR, Hecht F: Fragile Sites in Human Chromosomes (Oxford University Press, New York 1985).
155.
Tatarelli C, Linnenbach A, Mimori K, Croce CM: Characterization of the human testin gene localized in the FRA7G region at 7q31.2. Genomics 68:1–12 (2000).
156.
Tewari R, Juyal RC, Thelma BK, Das BC, Rao SR: Folate-sensitive fragile sites on the X-chromosome heterochromatin of the Indian mole rat, Nesokia indica. Cytogenet Cell Genet 44:11–17 (1987).
157.
Threadgill DW, Womack JE: Syntenic assignment of HSA9 and HSA12 homologs in the bovine. Preliminary evidence for the role of fragile sites in mammalian genome evolution. Cytogenet Cell Genet 51:1091 (1989).
158.
Tsai AG, Engelhart AE, Hatmal MM, Houston SI, Hud NV, et al: Conformational variants of duplex DNA correlated with cytosine-rich chromosomal fragile sites. J Biol Chem 284:7157–7164 (2009).
159.
Uchida IA, Freeman VC, Basrur PK: The fragile X in cattle. Am J Med Genet 23:557–562 (1986).
160.
Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, et al: Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905–914 (1991).
161.
White MJD: Cytogenetics of the grasshopper Moraba scurra. Aust J Zool 5:348–354 (1957).
162.
Wiechec E, Overgaard J, Hansen LL: A fragile site within the Hpc1 region at 1q25.3 affecting RGS16, RGSL1, and RGSL2 in human breast carcinomas. Genes Chromosomes Cancer 47:766–780 (2008).
163.
Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, et al: FRA3AB extends over a broad region and contains a spontaneous HPV16 integration site: Direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet 5:187–195 (1996).
164.
Williams AJ, Howell RT: A fragile secondary constriction on chromosome 2 in a severely mentally retarded patient. J Ment Defic Res 21:227–239 (1977).
165.
Winnepenninckx B, Debacker K, Ramsay J, Smeets D, Smits A, et al: CGG-repeat expansion in the DIP2B gene is associated with the fragile site FRA12A on chromosome 12q13.1. Am J Hum Genet 80:221–231 (2007).
166.
Wurster-Hill DH, Ward OG, Davis BH, Park JP, Moyzis RK: Fragile sites, telomeric DNA sequences, B chromosomes, and DNA content in raccoon dogs, Nyctereutes procyonoides, with comparative notes on foxes, coyote, wolf, and raccoon. Cytogenet Cell Genet 49:278–281 (1988).
167.
Yang MY, Long SE: Folate sensitive common fragile sites in chromosomes of the domestic pig (Sus scrofa). Res Vet Sci 55:231–235 (1993).
168.
Yu S, Pritchard M, Kremer E, Lynch M, Nancarrow J, et al: Fragile X genotype characterized by an unstable region of DNA. Science 252:1179–1181 (1991).
169.
Yu S, Mangelsdorf M, Hewett D, Hobson L, Baker E, et al: Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Cell 88:367–374 (1997).
170.
Yunis JJ, Soreng AL: Constitutive fragile sites and cancer. Science 226:1199–1204 (1984).
171.
Zhu Y, McAvoy S, Kuhn R, Smith DI: RORA, a large common fragile site gene, is involved in cellular stress response. Oncogene 25:2901–2908 (2006).
172.
Zlotorynski E, Rahat A, Skaug J, Ben-Porat N, Ozeri E, et al: Molecular basis for expression of common and rare fragile sites. Mol Cell Biol 23:7143–7151 (2003).
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.